Omada Health Reports Second Quarter 2025 Results
Omada Health, Inc. (Nasdaq: OMDA), the virtual between-visit healthcare provider, today reported financial results for the second quarter ended June 30, 2025.
Read Article
Press Release & Editorial
See Omada Health press releases and coverage activity.
-
-
Omada Health to Announce Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025
Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that it will release its second quarter 2025 results.
Read Article
-
Loading, please wait
Error - something went wrong!
Stay up to date with Omada
newsThank you!
-
Omada Health’s Enhanced GLP-1 Care Track Demonstrates Increased Medication Persistence and Weight Loss Outcomes at 12 and 24 Weeks
New GLP-1 analysis reveals that by addressing real-world barriers to persistence, Omada’s companion program can help sustain GLP-1 use, delivering on clinical trials' promises
Read Article
-
Omada Health Announces Pricing of Initial Public Offering
Omada Health, the virtual between-visit healthcare provider, today announced the pricing of its initial public offering of 7,900,000 shares of its common stock, at a public offering price of $19.00 pe
Read Article
-
Omada Health Announces Launch of Initial Public Offering
Omada Health announces its initial public offering, offering 7.9 million shares at $18–$20 each, and plans to list on Nasdaq under the ticker symbol “OMDA.”
Read Article
-
Omada Introduces Nutritional Intelligence to Transform Food Relationships with AI-Driven Tools and Human Care
Introducing Omada Health's Nutritional Intelligence with AI-powered OmadaSpark! Experience real-time support to tackle emotional eating & make informed, lasting food choices for a healthier lifestyle
Read Article
-
New Data Demonstrates Behavioral, Mental, and Physical Health Benefits of Omada Health’s Cardiometabolic Programs
Omada Health presented three posters at the Society of Behavioral Medicine's Annual Meeting. New data demonstrates behavioral, mental, and physical health benefits of Omada's cardiometabolic programs.
Read Article
-
Omada Health Enhances Clinical Advisory Board to Further Advance Clinical Excellence
Omada’s Clinical Advisory Board demonstrates its commitment to rigorous clinical evaluation and helps underscore the impact of its behavior change programs
Read Article
-
Doctors Report Concerns about Overprescribing and Continuity of Care with Patient Access to GLP-1 Medications through Third-Party Telehealth
In a survey of over 2,000 doctors, a majority believed GLP-1s need to be paired with changes in diet and exercise to be effective in driving healthy weight loss.
Read Article
-
New Analysis Shows Successful Weight Maintenance After GLP-1 Discontinuation When Paired with Omada Health Behavior Change Program
Real-world data analysis shows Omada members, on average, experienced virtually no weight gain 16 weeks after discontinuing a GLP-1 compared to an average of 6-7% weight gain estimated from trial data
Read Article
-
Omada Health Publishes Findings from Consumer Survey of GLP-1 Users
Survey finds only 18% of respondents who discontinued GLP-1s achieved their weight loss goals; respondents want to lose an average of 22% more weight.
Read Article
-
Anne Beal, MD, MPH Joins Omada Health Board of Directors
Dr. Beal brings extensive experience in clinical innovation, patient advocacy, and population health to Omada’s Board.
Read Article
-
Loading, please wait
Error - something went wrong!
Stay up to date with Omada
newsThank you!
-
Omada Health Partners with the State of Alaska to Reach Rural Populations
Through Alaska’s Fresh Start Campaign, Thousands of Residents Have Access to Omada’s Virtual Prevention, Diabetes, and Hypertension Coaching Programs
Read Article
-
Omada Health adds Sachin Jain, M.D., MBA, Julie Klapstein and Adam Stavisky to Board of Directors
New board members provide deep clinical and commercial experience.
Read Article
-
Omada Joins Pledge to White House-Supported Healthcare AI Commitments
Company pledges to keep humans at the center of care.
Read Article
-
New Research Shows Long-Term A1C Reduction and Sustained Weight Maintenance for Members in Omada Health’s Type 2 Diabetes Program
Omada Health, the virtual-first healthcare provider, published its 28th peer-reviewed study demonstrating the long-term outcomes of utilizing a behavior change program for members with type 2 diabetes
Read Article
-
New Data Published by Omada Health Demonstrates the Impact of Coupling GLP-1s and Behavior Change Programming
Findings show that meaningfully engaged Omada members on GLP-1s achieved an average of 1.7 times greater weight loss, and inform a new collaboration with Evernorth's EncircleRx program.
Read Article
-
Omada Health Expands Insights Lab to Advance Industry Learnings on Long-Term Weight Health
Building on more than a decade of insights and 28 peer-reviewed publications, Omada announces plans to develop more learnings focused on the long-term outcomes of GLP-1s on weight health
Read Article
-
Omada Health Enhances GLP-1 Care Track to Support Customers Managing Medications and Integrates MSK Support
Omada Health Enhances GLP-1 Care Track to Support Customers Managing Medications and Integrates MSK Support.
Read Article
-
Omada Health Joins Amazon’s Health Condition Programs as Launch Partner
The new offering will make it easier for Omada’s over 20 million eligible members to discover and enroll in Omada’s cardiometabolic programs.
Read Article
-
Loading More...
